Successful management of histoplasmosis with novel triazole antifungals: a brief report.
OBJECTIVES Standard therapy for histoplasmosis is often limited by drug-drug interactions, toxicity and variable pharmacokinetics. We report clinical experience using the novel triazoles posaconazole and isavuconazole as alternative treatment options. METHODS A retrospective case series was conducted. We analysed six...